Home >
daclizumab
daclizumab
RSS feeds
Articles 1 to 1 of 1 (1 miliseconds)
Abbott To Buy Facet Biotech For $450 Million
By: Andrew Taylor|2010-03-10|Business News
The Abbott Laboratories on Tuesday, March 09, said that the company will pay $450 million in cash for Facet Biotech Corp.
daclizumab in Related Categories
Top authors who wrote about "daclizumab"
Andrew Taylor - Andrew Taylor is the Manager of the Marketing Department of D&A Pharmaceuticals Company in Illinois State. He is a efficient cooperating writer of The New York Times.
Welcome, Guest! Log In | Create Account
